Liothyronine
Synthetic triiodothyronine (T3) for rapid thyroid hormone replacement and diagnostic use
Liothyronine is a synthetic form of triiodothyronine (T3), the biologically active thyroid hormone responsible for regulating metabolism, energy production, and body temperature. Unlike levothyroxine (T4), liothyronine acts directly on cells without requiring conversion and has a rapid onset of action. It is primarily prescribed when quick thyroid hormone effect is needed, such as during diagnostic evaluations, or in combination with levothyroxine when the body cannot adequately convert T4 to T3.
Quick Facts
Key Takeaways
- Liothyronine (T3) is the biologically active thyroid hormone with a rapid onset of action within 2–4 hours, unlike the slower-acting levothyroxine (T4)
- Primarily used when rapid thyroid hormone effect is needed, such as during diagnostic evaluations, or combined with levothyroxine when T4-to-T3 conversion is insufficient
- Take consistently each day at the same time in relation to meals — separate from calcium, iron, and antacid supplements by at least 4 hours
- Not recommended as the primary treatment for hypothyroidism during pregnancy because it does not cross the placenta effectively
- Must never be used for weight loss — taking thyroid hormones with normal thyroid function can cause serious cardiac side effects
What Is Liothyronine and What Is It Used For?
Quick Answer: Liothyronine is a synthetic version of triiodothyronine (T3), the active thyroid hormone. It is used when rapid thyroid hormone action is required, such as during diagnostic thyroid evaluations, and in combination with levothyroxine when the body does not adequately produce T3.
The thyroid gland produces two principal hormones: thyroxine (T4) and triiodothyronine (T3). While T4 is produced in much larger quantities, it is T3 that is the biologically active hormone responsible for regulating metabolism at the cellular level. Under normal circumstances, approximately 80% of the body's T3 is produced through peripheral conversion of T4 by deiodinase enzymes in the liver, kidneys, and other tissues. The remaining 20% is secreted directly by the thyroid gland.
Liothyronine sodium is a synthetic preparation of T3 that is chemically identical to the naturally occurring triiodothyronine. It binds directly to nuclear thyroid hormone receptors (TR-alpha and TR-beta) without requiring the deiodination step needed by levothyroxine. This direct mechanism of action accounts for its remarkably rapid onset — pharmacological effects begin within 2–4 hours of oral administration, compared to days or weeks for levothyroxine.
The half-life of liothyronine is approximately 1–2 days, which is considerably shorter than levothyroxine's 6–7 day half-life. This shorter duration of action means that liothyronine is metabolized and cleared from the body more quickly, making it particularly useful in clinical situations where rapid onset and rapid offset of thyroid hormone activity are desirable. However, the shorter half-life also means that blood levels of T3 fluctuate more throughout the day, which is one reason why levothyroxine remains the standard first-line therapy for chronic hypothyroidism.
The American Thyroid Association (ATA), European Thyroid Association (ETA), and British Thyroid Association (BTA) recognize liothyronine as a valuable therapeutic option in specific clinical scenarios, though they continue to recommend levothyroxine as the standard initial treatment for hypothyroidism.
Approved Uses
Liothyronine is approved and used for the following clinical indications:
- Diagnostic thyroid evaluations: When rapid onset and clearance of thyroid hormone effect is required for thyroid function testing, thyroid suppression tests, or radioactive iodine uptake studies
- Combination therapy with levothyroxine: In patients with hypothyroidism who have inadequate T4-to-T3 conversion in the body and remain symptomatic despite normal TSH levels on levothyroxine alone
- Myxedema coma (intravenous form): For emergency treatment of severe hypothyroidism with altered consciousness, where rapid thyroid hormone action is critical
- Thyroid cancer preparation: Short-term use before radioactive iodine therapy, allowing faster withdrawal of thyroid hormone compared to levothyroxine withdrawal
- Short-term thyroid suppression testing: To evaluate autonomous thyroid function and thyroid nodule assessment
Think of levothyroxine (T4) as a “storage” form of thyroid hormone and liothyronine (T3) as the “active” form. The body normally converts T4 to T3 as needed. Liothyronine bypasses this conversion step entirely, providing immediate thyroid hormone activity. This is why it is preferred in situations requiring rapid effect, but less suitable for long-term daily replacement where stable, consistent levels are important.
What Should You Know Before Taking Liothyronine?
Quick Answer: Before starting liothyronine, your doctor should evaluate your heart health, adrenal function, and current medications. Liothyronine is contraindicated in untreated adrenal insufficiency, untreated hyperthyroidism, and should be used with extreme caution in patients with cardiovascular disease.
Liothyronine is a potent thyroid hormone with a rapid onset of action, which means that its effects on the heart and metabolism are felt more quickly and intensely than with levothyroxine. This pharmacological profile requires careful patient assessment before initiating therapy. Your healthcare provider should conduct a thorough evaluation including blood tests for thyroid function, adrenal function, and cardiovascular assessment where appropriate.
Contraindications
Do not take liothyronine if you have any of the following conditions:
- Allergy to liothyronine sodium or any excipient in the formulation (including lactose, corn starch, talc, gelatin, or magnesium stearate)
- Untreated adrenal insufficiency and anterior pituitary insufficiency — these conditions must be corrected with appropriate hormone replacement before starting liothyronine, as thyroid hormones can precipitate an acute adrenal crisis
- Thyrotoxicosis (overactive thyroid) — adding exogenous T3 to an already hyperactive thyroid state is dangerous and can trigger thyroid storm
Warnings and Precautions
Liothyronine should never be used for weight loss purposes. In patients with normal thyroid function, taking thyroid hormones will not cause meaningful weight loss and can lead to serious or life-threatening adverse effects. The risk is particularly elevated when high doses of thyroid hormones are combined with weight-loss medications, potentially causing cardiac arrhythmias, angina, myocardial infarction, and thyrotoxicosis.
Cardiovascular disease: Patients with any form of heart disease — including coronary artery disease, angina pectoris, hypertension, arrhythmias, or heart failure — require extremely cautious dosing. Liothyronine's rapid onset of action places greater immediate stress on the cardiovascular system compared to levothyroxine. Starting doses should be very low and increased gradually under close medical supervision with ECG monitoring as needed.
Atherosclerosis and myxedema: Patients with advanced atherosclerosis or myxedema (severe hypothyroidism) are at increased risk of cardiac complications when thyroid hormone therapy is initiated too aggressively. In these patients, the rapid metabolic stimulation from liothyronine can trigger angina, myocardial infarction, or arrhythmias. Therapy should begin at the lowest possible dose.
Diabetes mellitus: Thyroid hormones can increase blood glucose levels by enhancing intestinal glucose absorption and hepatic gluconeogenesis. Patients with type 1 or type 2 diabetes may require dose adjustments of their insulin or oral hypoglycemic agents when starting, stopping, or adjusting liothyronine therapy. Blood glucose should be monitored more frequently during these transitions.
Biotin interference with laboratory tests: If you take biotin (vitamin B7, vitamin H, or vitamin B8) — including through multivitamins or supplements for hair, skin, and nails — you must inform your doctor and laboratory staff before undergoing thyroid blood tests. Biotin can interfere with immunoassay-based thyroid function tests, producing falsely elevated or falsely low results depending on the specific assay used. Your doctor may advise discontinuing biotin supplements 2–7 days before laboratory testing.
Pregnancy and Breastfeeding
Pregnancy: Clinical experience with liothyronine during pregnancy is limited. Importantly, liothyronine is not recommended for the treatment of hypothyroidism during pregnancy. The primary reason is that liothyronine (T3) does not adequately cross the placental barrier, meaning the developing fetus would not receive sufficient thyroid hormone. Adequate thyroid hormone delivery to the fetus is critical for normal brain development, particularly during the first trimester. Levothyroxine (T4), which crosses the placenta and is converted to T3 in fetal tissues, is the recommended treatment for hypothyroidism during pregnancy.
When liothyronine is used for diagnostic purposes during pregnancy, the potential benefits must be carefully weighed against the risks. Always consult your physician before using liothyronine during pregnancy.
Breastfeeding: Liothyronine passes into breast milk in small amounts, but the risk of adverse effects on the nursing infant is considered unlikely at therapeutic doses. Liothyronine can be used during breastfeeding, though the breastfed infant should be monitored for signs of thyroid dysfunction if the mother is taking high doses.
Driving and Operating Machinery
Liothyronine has no or negligible effect on the ability to drive vehicles or operate machinery when used at appropriate therapeutic doses. However, patients should be aware that if their dose is too high, symptoms such as tremors, nervousness, or heart palpitations may affect concentration and coordination. If you experience such symptoms, refrain from driving until your dose has been adjusted and symptoms have resolved.
Excipient Information
Lactose: Liothyronine tablets contain lactose as an excipient. If you have been told by your doctor that you have an intolerance to some sugars, contact your physician before taking this medication.
Sodium: This medicine contains less than 1 mmol (23 mg) sodium per tablet, meaning it is essentially sodium-free.
How Does Liothyronine Interact with Other Drugs?
Quick Answer: Liothyronine interacts with numerous medications including amiodarone, warfarin, digitalis, antidiabetic drugs, and many others. Several common supplements and medications must be taken at least 4 hours apart from liothyronine to avoid reduced absorption.
Drug interactions are a clinically important consideration with liothyronine therapy. Because thyroid hormones influence virtually every organ system in the body, changes in thyroid hormone levels can alter the effectiveness and safety profile of many co-administered medications. Conversely, numerous drugs can affect the absorption, metabolism, and activity of liothyronine itself. Patients should always provide their healthcare provider with a complete list of all medications, supplements, and herbal products they are taking.
Medications That Reduce Absorption
The following substances bind to liothyronine in the gastrointestinal tract and significantly reduce its absorption. They must be taken at least 4 hours apart from liothyronine:
| Medication/Substance | Effect on Liothyronine | Recommended Separation |
|---|---|---|
| Iron supplements | Binds to liothyronine, reducing GI absorption by up to 50% | At least 4 hours |
| Calcium supplements | Forms insoluble complexes, significantly reducing absorption | At least 4 hours |
| Aluminum-containing antacids | Adsorbs liothyronine in the GI tract, reducing bioavailability | At least 4 hours |
| Cholestyramine / Colestipol | Bile acid sequestrants bind thyroid hormones, reducing absorption substantially | At least 4 hours |
| Polystyrene sulfonate (Kayexalate) | Ion-exchange resin can bind thyroid hormones in the GI tract | At least 4 hours |
Medications That Alter Metabolism or Effect
| Medication | Interaction Effect | Clinical Action |
|---|---|---|
| Amiodarone | Contains high iodine content; can cause both hypothyroidism and hyperthyroidism; inhibits T4-to-T3 conversion | Regular thyroid monitoring required; dose adjustments likely |
| Warfarin and other anticoagulants | Liothyronine enhances the anticoagulant effect of coumarins, increasing bleeding risk | Monitor INR closely; may need warfarin dose reduction |
| Digitalis glycosides (Digoxin) | Thyroid hormones increase digoxin clearance, potentially reducing its therapeutic effect | Monitor digoxin levels; dose increase may be needed |
| Antidiabetic medications (Insulin, Metformin) | Thyroid hormones may increase blood glucose levels, reducing antidiabetic drug effectiveness | Monitor blood glucose more frequently; adjust diabetes medication as needed |
| Barbiturates, Carbamazepine, Phenytoin | Induce hepatic enzymes that increase thyroid hormone metabolism, potentially reducing liothyronine levels | Monitor thyroid function; dose increase may be required |
| St. John’s Wort (Hypericum perforatum) | Induces hepatic enzymes, potentially reducing thyroid hormone levels | Avoid combination; monitor thyroid function if used |
| Tricyclic antidepressants | Mutual potentiation — both liothyronine and TCAs can increase cardiac sensitivity and risk of arrhythmias | Use with caution; cardiac monitoring may be appropriate |
| Estrogen-containing medications (OCP, HRT) | Estrogen increases thyroxine-binding globulin (TBG), potentially altering thyroid hormone distribution | Monitor thyroid function; dose adjustment may be needed |
Biotin (vitamin B7/B8), found in many multivitamins and supplements for hair, skin, and nails, can interfere with immunoassay-based thyroid function tests. This can lead to falsely elevated or falsely low results depending on the test methodology. Inform your doctor and laboratory staff if you take biotin-containing supplements before any thyroid blood tests. Your physician may recommend stopping biotin 2–7 days before testing.
What Is the Correct Dosage of Liothyronine?
Quick Answer: Liothyronine dosage is highly individualized. The typical starting dose for adults is 5–20 mcg daily, adjusted based on clinical response and thyroid function tests. The tablet can be split into two equal doses. Always follow your doctor’s specific instructions.
Liothyronine dosing is determined individually by the prescribing physician based on the patient's clinical indication, thyroid function test results, cardiovascular status, age, and concomitant medications. Due to liothyronine's potent and rapid action, dosing must be carefully titrated to avoid both under-treatment and over-treatment. The following dosing information represents general guidelines; your doctor will prescribe the dose that is most appropriate for your specific situation.
Adults
Standard Replacement/Combination Therapy
When used in combination with levothyroxine for hypothyroidism, the typical liothyronine dose ranges from 5–20 mcg daily, divided into one or two doses. The ratio of T4:T3 replacement typically ranges from 13:1 to 20:1, reflecting the body's natural production ratio. Your physician will titrate the dose based on serum T3, T4, and TSH levels.
Diagnostic Use
For thyroid suppression testing and diagnostic evaluations, dosing protocols vary based on the specific test being performed. Your endocrinologist will provide detailed instructions for the testing protocol.
Children
Liothyronine use in children requires specialist supervision. Pediatric dosing is weight-based and indication-dependent. The prescribing pediatric endocrinologist will determine the appropriate dose based on the child's age, weight, thyroid function, and clinical response.
Elderly
Elderly patients are more sensitive to the cardiovascular effects of thyroid hormones. Starting doses should be lower than in younger adults, typically 5 mcg daily or less, with very gradual increases at intervals of 2–4 weeks. Cardiac monitoring is particularly important in elderly patients with known or suspected cardiovascular disease.
Administration Instructions
Swallow the tablet with a small amount of water. Liothyronine should be taken consistently each day at the same time in relation to meals. If your eating habits change significantly, your doctor may need to adjust your dose. The 20 mcg tablet has a score line and can be split into two equal 10 mcg doses. Place the tablet on a hard, flat surface with the score line facing up and press down with your index finger to break it.
Missed Dose
If you miss a dose, take it as soon as you remember, unless it is almost time for your next scheduled dose. In that case, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for the one you missed.
Overdose
If you have taken too much liothyronine, or if a child has accidentally ingested the medication, contact your doctor, hospital emergency department, or poison control center immediately for risk assessment and guidance.
Acute overdose (symptoms within 4–12 hours): Hyperactivity, restlessness, irritability, tremors, sweating, fever, palpitations, high blood pressure, diarrhea, insomnia, headache, and vomiting.
Subacute overdose: In addition to the above symptoms, there is risk of muscle weakness, confusion, seizures, coma, dehydration, cardiac arrhythmias, and circulatory shock.
Chronic overexposure: Moderate symptoms similar to acute overdose, along with weight loss, heat intolerance, and bone density loss.
What Are the Side Effects of Liothyronine?
Quick Answer: Most side effects of liothyronine are dose-related and resemble symptoms of hyperthyroidism. They include palpitations, rapid heart rate, tremors, nervousness, diarrhea, and headache. At correct therapeutic doses, liothyronine is generally well-tolerated.
Like all medications, liothyronine can cause side effects, although not everyone experiences them. The majority of adverse effects associated with liothyronine are dose-dependent, meaning they occur when the dose is too high or has been increased too quickly. These effects essentially represent symptoms of thyrotoxicosis (excessive thyroid hormone activity). When liothyronine is dosed correctly and titrated gradually, serious side effects are uncommon.
Because liothyronine has a faster onset of action than levothyroxine, side effects may appear more rapidly after dose initiation or adjustment. If you experience any of the following symptoms, particularly cardiac symptoms, contact your healthcare provider promptly — your dose may need to be reduced.
Cardiac Side Effects
Frequency not established (reported in post-marketing surveillance)
- Palpitations (awareness of heartbeat)
- Rapid heart rate (tachycardia)
- Cardiac arrhythmias (irregular heartbeat)
- Angina pectoris (chest pain)
Dose-Related Side Effects
Occur when dose is increased too quickly or is too high
- Palpitations and rapid heartbeat
- Diarrhea and abdominal discomfort
- Headache
- Tremors (shaking hands)
- Nervousness, anxiety, and restlessness
- Sweating and heat intolerance
- Insomnia
Other Reported Effects
Rare or with long-term excessive use
- Allergic skin reactions (hypersensitivity)
- Osteoporosis in women (with long-term excessive doses)
- Weight loss (indicates excessive dosing)
If you experience chest pain, significant palpitations, rapid or irregular heartbeat, severe headache, or excessive nervousness after starting liothyronine or after a dose increase, contact your healthcare provider promptly. These symptoms usually indicate that the dose is too high and needs to be reduced. Most side effects resolve quickly once the dose is adjusted, thanks to liothyronine’s relatively short half-life.
Reporting side effects: It is important to report suspected adverse reactions after a medication has been authorized. This enables ongoing monitoring of the medication’s benefit-risk balance. Healthcare professionals and patients are encouraged to report suspected side effects to their national pharmacovigilance authority.
How Should You Store Liothyronine?
Quick Answer: Store liothyronine at room temperature, away from light and moisture, and keep out of the reach of children. Do not use after the expiry date printed on the packaging.
Proper storage of liothyronine ensures the medication remains effective and safe throughout its shelf life. Incorrect storage conditions, particularly exposure to excessive heat or moisture, can degrade the active ingredient and reduce the tablet’s potency.
- Keep out of sight and reach of children — store in a location that is not accessible to young children
- Do not use after the expiry date printed on the packaging — the expiry date refers to the last day of the stated month
- Store at room temperature in the original container to protect from light and moisture
- Do not dispose of medications in household waste or down the drain — ask your pharmacist about proper disposal methods to protect the environment
What Does Liothyronine Contain?
Quick Answer: Each tablet contains 20 micrograms of liothyronine sodium as the active ingredient, along with lactose, corn starch, talc, gelatin (porcine origin), and magnesium stearate as excipients.
Understanding the full composition of your medication is important for identifying potential allergens or excipients that may cause intolerance. Liothyronine tablets contain the following ingredients:
| Component | Role | Notes |
|---|---|---|
| Liothyronine sodium 20 mcg | Active ingredient | Synthetic triiodothyronine (T3) |
| Lactose | Filler/binder | Inform your doctor if you have lactose intolerance |
| Corn starch (maize starch) | Disintegrant | Helps the tablet break apart in the GI tract |
| Talc | Glidant | Improves powder flow during manufacturing |
| Gelatin (porcine origin) | Binder | Derived from pork; relevant for dietary/religious considerations |
| Magnesium stearate | Lubricant | Prevents tablet from sticking to manufacturing equipment |
Liothyronine tablets are available in plastic containers of 100 tablets. The tablets have a score line allowing them to be divided into two equal halves of 10 mcg each.
Frequently Asked Questions About Liothyronine
Liothyronine (T3) is the biologically active thyroid hormone that acts directly on cells, while levothyroxine (T4) is a prohormone that must be converted to T3 by the body. Liothyronine has a much shorter half-life (1–2 days versus 6–7 days) and a faster onset of action (2–4 hours versus days to weeks). Levothyroxine provides more stable, consistent blood levels and is the standard first-line treatment for chronic hypothyroidism. Liothyronine is primarily reserved for situations requiring rapid thyroid hormone action or when patients cannot adequately convert T4 to T3.
Liothyronine is not recommended for treating hypothyroidism during pregnancy because T3 does not adequately cross the placenta. The developing fetus depends on maternal T4 (levothyroxine), which crosses the placenta and is converted to T3 in fetal tissues. If a pregnant woman takes only liothyronine, the fetus may not receive sufficient thyroid hormone for proper brain and neurological development. Levothyroxine is the recommended thyroid hormone replacement during pregnancy.
Yes, combination therapy with liothyronine and levothyroxine is used in selected patients who remain symptomatic on levothyroxine alone despite achieving normal TSH levels. This approach aims to replicate the thyroid gland’s natural production of both T4 and T3. The European Thyroid Association (ETA) suggests this may benefit a subset of hypothyroid patients. However, combination therapy requires careful dose titration and monitoring by an experienced endocrinologist.
Liothyronine has a rapid onset of action compared to other thyroid medications. Pharmacological effects begin within 2–4 hours of oral administration, with peak blood levels reached in approximately 2–4 hours. Clinical effects on metabolism, energy levels, and body temperature may be noticeable within hours to days. This rapid action makes liothyronine particularly useful for diagnostic testing and situations where quick thyroid hormone replacement is critical.
No. Liothyronine should never be used for weight loss. If your thyroid hormone levels are within the normal range, taking additional thyroid hormones will not produce meaningful weight loss and can cause dangerous side effects, including rapid heart rate, cardiac arrhythmias, bone density loss, and muscle wasting. The risk is even greater when combined with weight-loss supplements. All major medical guidelines explicitly prohibit the use of thyroid hormones for weight reduction in euthyroid individuals.
If you miss a dose of liothyronine, take it as soon as you remember unless it is nearly time for your next scheduled dose. In that case, skip the missed dose and take the next dose at the regular time. Do not take a double dose to compensate. Because liothyronine has a relatively short half-life, missing a single dose may result in temporary fluctuations in thyroid hormone levels, but this is unlikely to cause significant problems. If you frequently forget doses, consider setting a daily reminder.
References
- Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement. Thyroid. 2014;24(12):1670-1751. doi:10.1089/thy.2014.0028
- Wiersinga WM, Duntas L, Fadeyev V, et al. 2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of Hypothyroidism. European Thyroid Journal. 2012;1(2):55-71. doi:10.1159/000339444
- National Institute for Health and Care Excellence (NICE). Thyroid disease: assessment and management. NICE guideline [NG145]. 2019 (updated 2023). www.nice.org.uk/guidance/ng145
- British National Formulary (BNF). Liothyronine sodium. National Institute for Health and Care Excellence. 2025. bnf.nice.org.uk
- European Medicines Agency (EMA). Summary of Product Characteristics — Liothyronine sodium. www.ema.europa.eu
- World Health Organization (WHO). WHO Model List of Essential Medicines — 23rd List. 2023. www.who.int
- Biondi B, Wartofsky L. Combination treatment with T4 and T3: toward personalized replacement therapy in hypothyroidism? Journal of Clinical Endocrinology & Metabolism. 2012;97(7):2256-2271. doi:10.1210/jc.2011-3399
- Alexander EK, Pearce EN, Brent GA, et al. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid. 2017;27(3):315-389. doi:10.1089/thy.2016.0457
Editorial Team
This article has been written and reviewed by the iMedic Medical Editorial Team, consisting of licensed physicians with specializations in endocrinology and internal medicine. All content follows international medical guidelines and is based on peer-reviewed research with evidence level 1A.
iMedic Medical Editorial Team — specialists in endocrinology and clinical pharmacology with documented academic background and clinical experience in thyroid disorders.
iMedic Medical Review Board — independent panel of medical experts who review all content according to ATA, ETA, and WHO guidelines.
Last reviewed: | Evidence level: 1A (systematic reviews and meta-analyses of RCTs) | Guideline adherence: ATA 2014, ETA 2012, NICE NG145, BNF